Apoptosis inducer
The process of programmed cell death, or apoptosis, is generally characterized by distinct morphological characteristics and energy-dependent biochemical mechanisms. Apoptosis occurs normally during development and aging and as a homeostatic mechanism to maintain cell populations in tissues. It is considered a vital component of various processes including normal cell turnover, proper development and functioning of the immune system, hormone-dependent atrophy, embryonic development and chemical-induced cell death.
The alternative to apoptotic cell death is necrosis, which is considered to be a toxic process where the cell is a passive victim and follows an energy-independent mode of death. But since necrosis refers to the degradative processes that occur after cell death, it is considered by some to be an inappropriate term to describe a mechanism of cell death.
Using conventional histology, it is not always easy to distinguish apoptosis from necrosis, and they can occur simultaneously depending on factors such as the intensity and duration of the stimulus, the extent of ATP depletion and the availability of caspases. Necrosis is an uncontrolled and passive process that usually affects large fields of cells whereas apoptosis is controlled and energy-dependent and can affect individual or clusters of cells[1].
[1] S. Elmore. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 2007, 35, 495-516.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
2496 | 2,5-Dimethylcelecoxib | Celecoxib analog with anti-tumor properties, lacking COX-2 inhibitory activity | €75.00 | |
N0007 | Benastatin A | Glutathione S-Transferase (GST) π class inhibitor, anti-MRSA | Inquire | |
N0008 | Benastatin B | Glutathione S-Transferase (GST) π class inhibitor, anti-MRSA | Inquire | |
N0009 | Benastatin C | Glutathione S-Transferase (GST) π Class Inhibitor, activities on the murine lymphocyte blastogenesis. | Inquire | |
2431 | Chloroquine diphosphate | Classical antimalarial drug causing necrosis and apoptosis | €40.00 | |
3970 | CNDAC hydrochloride | Induces DNA damage and apoptosis. | €145.00 | |
N0014 | COMC | Inhibits the proliferation of B16 murine melanoma cells | Inquire | |
3825 | Cordycepin | Nucleoside analogue; Anticancer and anti-inflammatory agent | €60.00 | |
3459 | Dacarbazine | DNA alkylating agent; antineoplastic agent | €50.00 | |
3745 | Elesclomol | Apoptosis inducer | €90.00 | |
4149 | Everolimus | Selective and orally active mTOR1 inhibitor | Inquire | |
2432 | Hydroxychloroquine sulfate | Antimalarial drug with immunosuppressive and anti-inflammatory effects | €60.00 | |
1827 | IMS 2186 | Apoptosis inducer. Inhibitor of PGE2/TNF-α production | €95.00 | |
2327 | NEO 212 | DNA alkylating agent; chemotherapeutic | €110.00 | |
4045 | Nimustine hydrochloride | Water-soluble DNA alkylating agent | €90.00 | |
3826 | NUC-7738 | Prodrug of Cordycepin; Anticancer agent | €160.00 | |
2627 | SMER 28 | Small molecule enhancer of rapamycin that enhances autophagy | €80.00 | |
2894 | STF 62247 | Inducer of apoptosis and autophagy in VHL-deficient RCC cells | €85.00 | |
3149 | TC11 | Anti-tumor agent; Apoptosis inducer | €110.00 | |
2326 | Temozolomide | DNA methylating agent; apoptosis inducer | €50.00 |